detalle del documento
IDENTIFICACIÓN

doi:10.1186/s43046-024-00220-8...

Autor
Kouchaki, Hosein Kamyab, Parnia Darbeheshti, Farzaneh Gharezade, Arezou Fouladseresht, Hamed Tabrizi, Reza
Langue
en
Editor

Springer

Categoría

Medicine & Public Health

Año

2024

fecha de cotización

1/5/2024

Palabras clave
mir-939 cancer diagnostic prognostic therapeutic target cancer mir-939
Métrico

Resumen

Background MicroRNAs (miRNAs or miRs) are highly conserved non-coding RNAs with a short length (18–24 nucleotides) that directly bind to a complementary sequence within 3′-untranslated regions of their target mRNAs and regulate gene expression, post-transcriptionally.

They play crucial roles in diverse biological processes, including cell proliferation, apoptosis, and differentiation.

In the context of cancer, miRNAs are key regulators of growth, angiogenesis, metastasis, and drug resistance.

Main body This review primarily focuses on miR-939 and its expanding roles and target genes in cancer pathogenesis.

It compiles findings from various investigations.

MiRNAs, due to their dysregulated expression in tumor environments, hold potential as cancer biomarkers.

Several studies have highlighted the dysregulation of miR-939 expression in human cancers.

Conclusion Our study highlights the potential of miR-939 as a valuable target in cancer diagnosis, prognosis, and treatment.

The aberrant expression of miR-939, along with other miRNAs, underscores their significance in advancing our understanding of cancer biology and their promise in personalized cancer care.

Kouchaki, Hosein,Kamyab, Parnia,Darbeheshti, Farzaneh,Gharezade, Arezou,Fouladseresht, Hamed,Tabrizi, Reza, 2024, miR-939, as an important regulator in various cancers pathogenesis, has diagnostic, prognostic, and therapeutic values: a review, Springer

Documento

Abrir

Compartir

Fuente

Artículos recomendados por ES/IODE IA

Systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for lung cancer
agphd1 subtypes replication hykk squamous cell gene carcinoma causal targets mendelian randomization cancer analysis